在患有牛皮关节炎的成年人中使用risankizumab
Karla Machlab1, Jensen Yeung2,3, Melinda Gooderham4,5,6
1Department of Medicine, University of Toronto, ON, Canada.
Skin therapy letter
|November 28, 2023
概括
瑞桑基祖马布通过向互白素-23.3来有效治疗牛皮性关节炎 (PsA). 临床试验证实了其在减少关节胀和皮肤病变方面的安全性和有效性,改善了患者的生活质量.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 皮肤病学 皮肤病学
背景情况:
- 牛皮关节炎 (PsA) 是一种慢性炎症状况,影响牛皮患者的关节和皮肤.
- 介质素-23 (IL-23) 在PsA病理生理学中起着关键作用,驱动炎症和骨重塑.
- 目前的治疗方法旨在控制PSA症状和潜在的免疫调节障碍.
研究的目的:
- 审查瑞桑基祖马布 (risankizumab) 在治疗牛皮关节炎的疗效和安全性.
- 在PSA中对risankizumab进行24周和52周的临床试验结果.
- 评估瑞桑基祖马布对关节,皮肤和生活质量影响的结果.
主要方法:
- 进行了2期和3期临床试验,以评估PsA患者的瑞桑基祖马布.
- 参与者接受了针对IL-23的单克隆抗体RISANKIZUMAB.
- 疗效终点包括关节计数,皮肤清除和生活质量测量.
主要成果:
- 瑞桑基祖马布在减少胀和疼痛关节数量方面表现出显著的有效性.
- 观察到牛皮斑清除和改善患者报告的生活质量.
- 治疗耐受性很好,上呼吸道感染是最常见的不良事件.
结论:
- 瑞桑基祖马布是适度至严重的牛皮关节炎的安全有效的治疗选择.
- 用瑞桑基祖马布向IL-23提供了一种有价值的治疗策略.
- 长期数据支持瑞桑基祖马布在PsA管理中的持续益处和耐受性.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
143
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
143
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
121
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
121
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
188
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
188
01:29Drugs for Treatment of Ulcerative Colitis in IBD
145
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
145
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K